Interview with Scott Berry

What is your current role in EPAD? I am a co-lead of Work Package 2 – The Statistical Engine Room.  The Statistical Work Package has two main focuses in the EPAD project – the design of the proof-of-concept platform trial and the disease modeling work from the Longitudinal Cohort Study (LCS).  I have been focused…

EPAD makes the front cover of the Sunday Post

Professor Craig Ritchie, of the University of Edinburgh, is jointly leading the EPAD project, a Europe-wide collaboration aiming to improve the understanding of the early stages of Alzheimer’s disease. EPAD combines knowledge and expertise from 39 European partner organisations across multiple sectors. Craig Ritchie and one of the EPAD study participants Eileen Penman have recently been…

EPAD is showcased as a good practice of communications

On 2 April, the Innovative Medicines Initiative (IMI) organised a Projects Communication Event, which brought together more than 70 representatives from many IMI projects responsible for communications. Several members of the EPAD project travelled to Brussels to take part in this exciting event and shared their experiences within our WP6 on Dissemination. The aim of…

Fundació ACE joins EPAD for dementia prevention

Fundació ACE – Barcelona Alzheimer Treatment & Research Center, an entity devoted to the diagnosis, treatment, research and awareness on Alzheimer’s disease, has been incorporated into EPAD (European Prevention of Alzheimer’s Dementia Consortium), a European consortium aiming to work for the prevention of Alzheimer’s dementia through an interdisciplinary research program. Facing the evidence that Alzheimer’s…

Spotlight on University of Edinburgh/NHS Lothian

The European Prevention of Alzheimer’s Dementia initiative (EPAD) recruited its first Research Participant in May 2016 via the University of Edinburgh (UK). The team of Craig Ritchie (principal investigator of the EPAD project in the University of Edinburgh and EPAD Project Co-coordinator) has currently recruited over 100 participants in the EPAD Longitudinal Cohort Study (LCS).…

EPAD presented at the AD/PD conference

The 14th​ International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2019) and related neurological disorders took place in Lisbon (Portugal) from 26-31 March. It provided a world class platform for international clinical investigators and scientists to present, discuss and trade expertise on a broad range of themes and topics. The event attracted over 3,800 participants from…

The EPAD Longitudinal Cohort Study has now over 1,500 Research Participants

On 7 March, EPAD passes the mark of 1.500 research participants for its Longitudinal Cohort Study (LCS)! Congratulations to the Trial Delivery Center in Bristol, who recruited participant number 1500. The largest ever public-private partnership in Alzheimer’s disease research, EPAD combines knowledge and expertise from 39 organisations across multiple sectors from academia and industry, bringing…

EPAD works together towards the PoC platform

2019 started with great intensity! On 5 February, EPAD held its PoC (Proof of Concept) Kick Off meeting in Berlin, Germany. The event brought together more than 100 delegates including site staff (principal investigators, sub-investigators, study coordinators, national leads), vendors and the wider EPAD PoC coordination team (the University of Edinburgh, Janssen, IQVIA) to showcase…

EPAD holds its Investigator meeting

On 4 February, over 90 representatives of the EPAD project met in Berlin. Participants included 15 dedicated teams from UK, Spain, Germany, Italy, Belgium and Greece together with representatives from the University of Edinburgh, Clinical Research Organisations, IQVIA and Janssen. The objective of the meeting was to prepare the new trial delivery centres (TDCs) to…